Vismodegib Drug Interactions

Brand name
  • Erivedge
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Vismodegib

Vismodegib is used to treat basal cell carcinoma (a type of skin cancer) in people with cancer that has spread to other parts of the body. Vismodegib is also used to treat basal cell carcinoma that cannot be treated with surgery or radiation or has come back after surgery.

Read the full Vismodegib drug information page 

The Bottom Line on Vismodegib

With vismodegib, the interaction problem you will meet most often is the medicine simply working less well, and sometimes another medicine's level in your blood running higher. Since this treatment is aimed at skin cancer that has spread or can't be treated with surgery or radiation, you want it to get its full effect.

Its number of documented interactions is about typical, but most of them are rated major, and nine are contraindicated. Omeprazole, one of the most widely used medicines, is rated major because it can lower how much vismodegib your body takes in.

Of the supplements, herbs and foods with a rated interaction, two are rated major, and a pharmacist can check the ones you take. Filling every prescription at one pharmacy lets each new one be checked against vismodegib.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Vismodegib Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented vismodegib interaction, supplements and herbs included.

    What Could Happen When Vismodegib Interacts

    What the 54 documented vismodegib interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own section below. One interaction can name more than one problem, so the numbers add up to more than 54.

    Vismodegib Interactions by Severity

    Vismodegib With Supplements and Herbs

    Supplements can interact with vismodegib too. The Natural Medicines database, which we license, rates 58 of them for an interaction with vismodegib, and every one of the 1,327 supplements and herbs we cover has a page on taking it with vismodegib.

    Rated for an Interaction With Vismodegib

    Every Supplement and Herb With Vismodegib, A to Z1,327 pages

    Each one opens its page on taking it with vismodegib, whether or not an interaction is rated.

    Browse every supplement and herb 

    Check a supplement bottle against vismodegib with our drug–supplement interaction checker, or scan its label.

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Vismodegib meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Vismodegib?

    Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Vismodegib’s Interactions

    The 40 sources our vismodegib interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Product Information: ERIVEDGE(R) oral capsules, vismodegib oral capsules. Genentech USA Inc (per FDA), South San Francisco, CA, 2019. DailyMed 
    2. Calik J, Oslizlo M, Slocka-Romaniuk B, et al: Case report: sequential treatment strategy for advanced basal cell carcinoma in Gorlin-Goltz syndrome: integration of vismodegib, radiotherapy, surgery, and high-intensity focused ultrasound. Front Oncol 2024; 14:1428702. PubMed 
    3. Kesireddy M, Mendiola VL, Jana B, et al: Long-term response to vismodegib in a patient with Gorlin-Goltz syndrome: a case report and review of pathological mechanisms involved. Cureus 2019; 11(8):e538. PubMed 
    4. Palmeiro AG, Carvalho M, Goncalves Castro C, et al: Vismodegib in Gorlin-Goltz syndrome: a systematic review. Australas J Dermatol 2024; 65(6):e123-e133. PubMed 
    5. Verkouteren BJA, Cosgun B, Reinders MGHC, et al: A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome). Br J Dermatol 2022; 186(2):215-226. PubMed 
    6. Product Information: ERIVEDGE(TM) oral capsules, vismodegib oral capsules. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2012. DailyMed 
    7. Jacobsen AA, Aldahan AS, Hughes OB, et al: Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies. JAMA Dermatol 2016; 152(7):816-824. PubMed 
    8. Sekulic A, Migden MR, Oro AE, et al: Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366(23):2171-2179. PubMed 
    9. Product Information: ERIVEDGE(R) oral capsules, vismodegib oral capsules. Genentech USA Inc (per FDA), South San Francisco, CA, 2019. DailyMed 
    10. Krens SD, Lassche G, Jansman FGA, et al: Dose recommendations for anticancer drugs in patients with renal or hepatic impairment. Lancet Oncol 2019; 20(4):e200-e207. PubMed 

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.